Suppr超能文献

超速抑制在病态窦房结综合征诊断中的应用

Overdrive suppression in diagnosis of sick sinus syndrome.

作者信息

Toyama J, Ito A, Sawada K, Ito T, Tanahashi Y

出版信息

J Electrocardiol. 1975 Jul;8(3):209-16. doi: 10.1016/s0022-0736(75)80047-1.

Abstract

A criterion to determine the indication for pacemaker implantation in the sick sinus syndrome by overdrive suppression is proposed. Overdrive suppression was performed in 10 patients with the sick sinus syndrome (SSS) and another 10 patients with normal sinus rhythm (NSR) who served as controls. In the SSS group, 9 patients had complained of such severe symptoms as Adams-Stokes attack and/or congestive failure and were referred to our laboratory for pacemaker implantation. One other patient, an apparently robust young man (20 years old) referred for detailed cardiac examination, had no remarkable symptoms except for arrhythmias, but was found dead two months later. Atrial pacing for overdrive suppression was carried out at first at various rates ranging from 60 to 180 beats/min for 15 sec, and then at a rate of 100 beats/min for various durations ranging from 5 to 180 sec. After cessation of the atrial pacing, asystolic pauses were measured and the maximum (maximum pause) among the pauses obtained was used as a parameter indicating depression of cardiac automaticity. The maximum pause in the SSS group ranged from 5.6 to 9.0 sec (mean +/- SD = 7.0 +/- 1.2), WHILE THOSE IN THE NSR group ranged from 0.7 to 1.5 sec (mean +/- SD = 1.2 +/- 0.14). Therefore, the maximum pause was considered not only to reflect the severity of the symptoms necessitating pacemaker implantation in the 9 patients of the SSS group but to have warned us of sudder death in another patient. We concluded that overdrive suppression is useful as a supplementary challenge to determine indications for pacemaker implantation for the sick sinus syndrome, and that prolongation of the maximum pause beyond 5.0 sec is the critical level for pacemaker implantation.

摘要

提出了一种通过超速抑制来确定病态窦房结综合征患者起搏器植入指征的标准。对10例病态窦房结综合征(SSS)患者和另外10例作为对照的正常窦性心律(NSR)患者进行了超速抑制。在SSS组中,9例患者曾抱怨有阿-斯发作和/或充血性心力衰竭等严重症状,并被转诊至我们实验室进行起搏器植入。另1例患者是一名看似健壮的年轻人(20岁),因详细的心脏检查前来就诊,除心律失常外无明显症状,但两个月后死亡。首先以60至180次/分钟的不同频率进行心房起搏超速抑制15秒,然后以100次/分钟的频率进行5至180秒的不同时长起搏。心房起搏停止后,测量停搏间期,将所获得的停搏间期中的最大值(最大停搏)作为指示心脏自律性抑制的参数。SSS组的最大停搏范围为5.6至9.0秒(均值±标准差=7.0±1.2),而NSR组的最大停搏范围为0.7至1.5秒(均值±标准差=1.2±0.14)。因此,最大停搏不仅被认为反映了SSS组9例患者中需要植入起搏器的症状严重程度,还警示了另一例患者的猝死。我们得出结论,超速抑制作为一种补充性激发试验,对于确定病态窦房结综合征患者起搏器植入指征是有用的,且最大停搏超过5.0秒的延长是起搏器植入的临界水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验